Soc. Generale Knock-Out MRK/ DE000CL7GXA6 /
2024-05-22 11:35:41 AM | Chg.+0.07 | Bid12:29:02 PM | Ask12:29:02 PM | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
7.52EUR | +0.94% | 7.46 Bid Size: 10,000 |
7.47 Ask Size: 10,000 |
MERCK KGAA O.N. | 91.924 - | 2078-12-31 | Call |
GlobeNewswire
05-07
CytomX Therapeutics Announces Clinical Collaboration with Merck to Evaluate CX-801 in Combination wi...
GlobeNewswire
05-06
Press Release Biocartis NV: Biocartis and Merck to Collaborate on Improving Patient Access to Person...
GlobeNewswire
03-04
C4 Therapeutics Announces Strategic Discovery Research Collaboration with Merck KGaA, Darmstadt, Ger...
GlobeNewswire
2023-12-21
Arch Biopartners Receives Approval from Ethics Committee in Turkey to Proceed with Phase II Cardiac ...
GlobeNewswire
2023-12-14
ITM Executes License Agreement to Obtain Worldwide Exclusive License for the Clinical Development an...
GlobeNewswire
2023-10-17
ImmunOs Therapeutics Announces Clinical Trial Collaboration with Merck & Co., Inc., Rahway, NJ, USA